- Home
- ADXN vs SNOA Comparison
ADXN vs SNOA Comparison
Compare ADXN & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- SNOA
- Stock Information
- Founded
- ADXN 2002
- SNOA 1999
- Country
- ADXN Switzerland
- SNOA United States
- Employees
- ADXN N/A
- SNOA N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- SNOA Health Care
- Exchange
- ADXN Nasdaq
- SNOA Nasdaq
- Market Cap
- ADXN 8.0M
- SNOA 7.5M
- IPO Year
- ADXN N/A
- SNOA 2007
- Fundamental
- Price
- ADXN $9.51
- SNOA $4.07
- Analyst Decision
- ADXN Strong Buy
- SNOA
- Analyst Count
- ADXN 1
- SNOA 0
- Target Price
- ADXN $30.00
- SNOA N/A
- AVG Volume (30 Days)
- ADXN 60.1K
- SNOA 109.7K
- Earning Date
- ADXN 09-01-2025
- SNOA 11-06-2025
- Dividend Yield
- ADXN N/A
- SNOA N/A
- EPS Growth
- ADXN N/A
- SNOA N/A
- EPS
- ADXN 0.10
- SNOA N/A
- Revenue
- ADXN $278,508.00
- SNOA $14,912,000.00
- Revenue This Year
- ADXN $86.57
- SNOA $23.00
- Revenue Next Year
- ADXN N/A
- SNOA $24.59
- P/E Ratio
- ADXN $0.85
- SNOA N/A
- Revenue Growth
- ADXN N/A
- SNOA 17.43
- 52 Week Low
- ADXN $6.51
- SNOA $1.75
- 52 Week High
- ADXN $12.05
- SNOA $6.92
- Technical
- Relative Strength Index (RSI)
- ADXN 61.03
- SNOA 50.04
- Support Level
- ADXN $7.70
- SNOA N/A
- Resistance Level
- ADXN $12.05
- SNOA $4.68
- Average True Range (ATR)
- ADXN 0.33
- SNOA 0.20
- MACD
- ADXN 0.22
- SNOA -0.26
- Stochastic Oscillator
- ADXN 41.61
- SNOA 84.44
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.